Ajanta Pharma Share Price Ajanta Pharma

1,425.55

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

1,433.50

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 11-May-2020 - -
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Wednesday, 20th May 2020 through video conference or other audio visual means, in accordance with the notification (Companies (Meetings of Board and its Powers) Amendment Rules, 2020) issued by the Ministry of Corporate Affairs dated 19th March 2020, to consider and approve inter-alia: a. Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2020; and b. Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2020. In terms of SEBI circular no. SEBI/HO/CFD/CMD1/CIR/P/2020/48 dated 26th March 2020, there shall be no publication of notice in the newspapers in this regard. Kindly take the above information on record. We hereby inform that the Board of Directors at its meeting held on Wednesday, 20th May 2020, has inter alia approved and took on record the Audited (Consolidated & Standalone) Financial Results of the Company for the quarter and year ended 31st March 2020; Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following: 1. Press Release; 2. Audited Consolidated Financial Results for the quarter and year ended 31st March 2020 along with Auditors report with unmodified opinion; 3. Audited Standalone Financial Results for the quarter and year ended 31st March 2020 along with Auditors report with unmodified opinion; 4. Investors presentation. We shall inform in due course, date of the 41st Annual General Meeting to be held for the year ended 31st March 2020. Meeting of the Board of Directors commenced at 2.00 p.m. and concluded at 4.20 p.m. Kindly take the above on your records. (As Per BSE Announcement dated on 20.05.2020)
Board Meeting - 20-Jan-2020 - -
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Wednesday, 5th February 2020 in Mumbai to inter-alia consider and approve unaudited consolidated and standalone financial results of the Company for the third quarter ended 3lst December 2019. Kindly take note of the same and inform your members suitably. Please find enclosed herewith following: i. Press Release being issued on the Results for the third quarter ended 31st December 2019; ii. Unaudited Consolidated Financial Results for the third quarter ended 31st December 2019; iii. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Consolidated Financial Results for the third quarter ended 31st December 2019; iv. Unaudited Standalone Financial Results for the third quarter ended 31st December 2019; v. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Standalone Financial Results for the third quarter ended 31st December 2019. Kindly note that the meeting of the Board of Directors commenced at 3.30 p.m. and concluded at 5.45 p.m. (As Per BSE Announcement Dated on 05/02/2020)
Board Meeting - 22-Oct-2019 - -
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Tuesday, 5th November 2019 to inter-alia: 1. Approve and take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2019; 2. Consider declaration of interim dividend. Pursuant to Regulation 42 of the Listing Regulations, please take notice that the Record date for determining the shareholders entitled to the interim dividend, if declared by the Board, will be Monday, 18th November 2019. Kindly take the above on your records and disseminate the same to your members. Ajanta Pharma Ltd has informed BSE that the Company has fixed November 18, 2019 as the Record Date for the purpose of Payment of Interim Dividend. (As Per BSE Announcement Dated on 23/10/2019) Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held on November 05, 2019, inter alia, have approved payment of interim dividend of Rs. 13/- (650%) per equity share on the face-value of Rs. 2/- per share for the Financial Year 2019-20: Further, lnterim dividend will be paid on or after November 20, 2019. Pursuant to Regulations 33, 42 & 43 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that Board of Directors of Company have at their meeting held on 5th November 2019, approved the following: i. Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended 30th September 2019; ii. Payment of interim dividend of Rs. 13/- (650%) per equity share on the face-value of Rs. 2/- per share for the Financial Year 2019-20; iii. Fixed Monday, 18th November 2019 as the record date for payment of interim dividend. lnterim dividend will be paid on or after 20th November 2019. Kindly note that the meeting of the Board of Directors commenced at 3.30 p.m. and concluded at 5.30 p.m. and take the above on your records. (As Per BSE Announcement Dated on 11/5/2019)
Board Meeting - 19-Jul-2019 - -
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Wednesday, 31st July 2019 in Mumbai to inter-alia consider and approve unaudited consolidated and standalone financial results of the Company for the first quarter ended 30th June 2019. Pursuant to Regulation 47 of the Listing Regulations, please find enclosed intimation about the meeting of Board of Directors of the Company to be held on Wednesday, 31st July 2019 published in the following newspapers on 20th July 2019: 1. Mumbai edition of The Free Press Journal and 2. Mumbai edition of Navshakti; This is for your information and record. (As Per BSE Announcement Dated 22.07.2019) At the Board meeting held today, the Board has inter alia approved and taken on record Unaudited Financial results for the quarter ended 30th June 2019. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following: i. Press Release being issued on the Results for the quarter ended 30th June 2019; ii. Unaudited Consolidated Financial Results for the quarter ended 30th June 2019; iii. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Consolidated Financial Results for the quarter ended 30th June 2019; iv. Unaudited Standalone Financial Results for the quarter ended 30th June 2019; v. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Standalone Financial Results for the quarter ended 30th June 2019. Kindly note that the meeting of the Board of Directors commenced at 2.30 p.m. and concluded at 5.10 p.m. and take the above on your records (As Per BSE Announcement Dated on 31/07/2019)